MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Zytronic shares dive amid ‘sustained lack of recovery’

ALN

Zytronic PLC said on Wednesday that a failure to recover its business performance has prompted the launch of a strategic review.

The specialist manufacturer of touch sensors said that it had experienced ‘disappointing volumes’ in the year ended 30 September, with management contending that the required improvement would be unlikely without a ‘strategic catalyst’.

The AIM-listed firm’s trading update detailed full-year revenue slipping 16% to £7.1 million from £8.6 million the year prior.

Despite indications that revenue will be second-half weighted this year, with Zytronic anticipating a 22% increase to £3.9 million from £3.3 million, its board ‘does not anticipate a material recovery in volumes over the short to medium term’.

Shares in Zytronic were trading down 11% at 47.80 pence in afternoon trading in London on Wednesday.

The strategic review will assess the merits of five key options for Zytronic, including both a liquidation of its assets and a sale of the business. Regarding the latter, Zytronic stated that it has not yet entered into any discussions with any potential offerer.

The review will be undertaken in collaboration with shareholders, with Zytronic intending to engage in discussions regarding their investment priorities.

Whilst no specific timeline has been outlined, the market can expect ‘further announcements in due course’ pertaining to the progress of the review.

Copyright 2024 Alliance News Ltd. All Rights Reserved.